Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Syst ème National des Données de Santé (SNDS) database: a retrospective cohort study
ConclusionsThis study showed a high economic burden of MM in France ( €72.37 K/patient/year in the first year) and the diversity of regimens used in late-line treatments.
Source: The European Journal of Health Economics - Category: Health Management Source Type: research
More News: Databases & Libraries | Economics | France Health | Health Management | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants